Besides, we further elucidated the predictive value of RNF43 for the immunotherapy efficacy and drug sensitivity in pan-cancer, thus highlighting the promising role of RNF43 as a clinical biomarker and a novel therapeutic target for cancer patients in clinic settings. Here, RNF43 is linked to cancer.